- Cat.No. Nom du produit Informations
- GC52376 BMP2-derived Peptide (trifluoroacetate salt) A synthetic peptide
- GC52361 AMARA Peptide (trifluoroacetate salt) A peptide substrate for AMPK
- GC36733 NGR peptide Trifluoroacetate Peptide NGR Le trifluoroacétate contenant le motif asparagine-glycine-arginine (NGR) est reconnu par les isoformes du récepteur CD13/aminopeptidase N (APN) qui sont sélectivement surexprimées dans la néovascularisation tumorale.
- GC44536 PACAP-related Peptide (rat) (trifluoroacetate salt) PACAP-related peptide (PRP) is an endogenous 29-amino acid peptide that belongs to the secretin/glucagon superfamily of peptides, which includes secretin, glucagon, glucagon-like peptide-1, GLP-2, and pituitary adenylate cyclase-activating polypeptide.
- GC52253 α-Enolase (1-19)-biotin Peptide A biotinylated α-enolase peptide
- GC52351 Citrullinated α-Enolase (R8 + R14) (1-19)-biotin Peptide A biotinylated and citrullinated α-enolase peptide
- GC43764 GLP-2 (human) (trifluoroacetate salt) Glucagon-like peptide-2 (GLP-2) is an endogenous peptide hormone formed in L cells of the small and large intestine by cleavage of proglucagon in response to nutrient ingestion.
- GC43567 DPC-AJ1951 (trifluoroacetate salt) DPC-AJ1951 is a peptide agonist of the parathyroid hormone (PTH)/PTH-related peptide receptor (PPR; EC50 = 0.15 nM in HEK293 cells expressing human PPR).
- GC52390 Spexin 1 (human, mouse, rat, bovine) (acetate) An endogenous peptide and agonist of GAL2 and GAL3
- GC49885 BQ-3020 (trifluoroacetate salt) A peptide ETB receptor antagonist
- GC49543 Hepcidin-25 (trifluoroacetate salt) A peptide hormone
- GC49475 Triptorelin (trifluoroacetate salt) A synthetic GNRH peptide agonist
- GC49416 Gap 27 (trifluoroacetate salt) A connexin-mimetic peptide
- GC49143 Deslorelin (acetate) A peptide agonist of GnRH
- GC48989 LTX-315 (trifluoroacetate salt) A synthetic cationic amphiphilic peptide
- GC48401 Risuteganib (trifluoroacetate salt) An anti-integrin peptide
- GC48348 Carbetocin (acetate) La carbétocine (acétate), un analogue de l'ocytocine (OT), est un agoniste des récepteurs de l'ocytocine avec un Ki de 7,1 nM.
- GC48328 Obestatin (human) (trifluoroacetate salt) A peptide hormone
- GC45490 Kisspeptin-54 (human) (trifluoroacetate salt)
- GC45062 TNF-α Antagonist TNF-α antagonist is an exocyclic peptide that mimics the critical TNF-α recognition loop on TNF receptor I complex and, thus, prevents ligand interaction with the receptor.
- GC44518 Osteocalcin (1-49) (human) (trifluoroacetate salt) Osteocalcin (1-49) is a non-collagenous peptide that is secreted by osteoblasts and odontoblasts and comprises 1-2% of the total protein in bone.
- GC44374 Neuromedin B (trifluoroacetate salt) Neuromedin B (NMB) is a peptide agonist of the NMB receptor (Ki = 7.4 nM in NCI-H1299 small cell lung cancer cells expressing the human receptor).
- GC43890 ICI 216140 Bombesin is a peptide, originally isolated from the skin of the European fire-bellied toad, with pressor and sympathoexcitatory activity.
- GC43784 GRP (human) (trifluoroacetate salt) Gastrin-releasing peptide (GRP) is a neuropeptide that stimulates gastrin release.
- GC43127 Calcitonin (salmon) (trifluoroacetate salt) Calcitonin is a peptide hormone that lowers blood calcium level and inhibits bone resorption.
- GC32772 Triptorelin ([DTrp6]-LH-RH) A synthetic GNRH peptide agonist
- GC11979 C3bot (154-182) C3bot (154-182) est un peptide C3 qui améliore la récupération après une lésion de la moelle épinière en améliorant la croissance régénérative des faisceaux de fibres descendantes.
- GC15356 Prion Protein 106-126 (human) La protéine prion 106-126 (humaine), un fragment peptidique du prion, peut induire l'apoptose neuronale, la digestion de l'antiprotéinase K, la formation de fibres et assurer la conversion de la protéine prion cellulaire normale (PrPc) en isoforme pathogène (PrPSc).
- GC16175 Nogo-66 (1-40) Nogo-66 (1-40) est un peptide antagoniste du récepteur Nogo-66 (NgR), inversant le changement induit par la blessure dans la distribution des morphologies de la microglie en limitant l'inhibition À base de myéline.